EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische Studie

Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis

Sebastián Marciano iD, Salvatore Piano iD, Virendra Singh iD, Paolo Caraceni iD, Rakhi Maiwall iD, Carlo Alessandria, Javier Fernandez, Dong Joon Kim iD, Sung Eun Kim iD, Elza Soares iD, Mónica Marino, Julio Vorobioff und 17 weitere

Liver International · 2024

DOI: 10.1111/liv.16063 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Liver International, 2024. Verfasst von Sebastián Marciano und 28 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit and Research Department, Hospital Italiano Buenos Aires, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Liver Cirrhosis, Drug Resistance, Multiple, Bacterial, Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the increasing rate of infections caused by multidrug‐resistant organisms (MDRO), selecting appropriate empiric antibiotics has become challenging. We aimed to develop and externally validate a model for predicting the risk of MDRO infections in patients with cirrhosis.

Methods

We included patients with cirrhosis and bacterial infections from two prospective studies: a transcontinental study was used for model development and internal validation ( n = 1302), and a study from Argentina and Uruguay was used for external validation ( n = 472). All predictors were measured at the time of infection. Both culture‐positive and culture‐negative infections were included. The model was developed using logistic regression with backward stepwise predictor selection. We externally validated the optimism‐adjusted model using calibration and discrimination statistics and evaluated its clinical utility.

Results

The prevalence of MDRO infections was 19% and 22% in the development and external validation datasets, respectively. The model's predictors were sex, prior antibiotic use, type and site of infection, MELD‐Na, use of vasopressors, acute‐on‐chronic liver failure, and interaction terms. Upon external validation, the calibration slope was 77 (95% CI .48–1.05), and the area under the ROC curve was .68 (95% CI .61–.73). The application of the model significantly changed the post‐test probability of having an MDRO infection, identifying patients with nosocomial infection at very low risk (8%) and patients with community‐acquired infections at significant risk (36%).

Conclusion

This model achieved adequate performance and could be used to improve the selection of empiric antibiotics, aligning with other antibiotic stewardship program strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisDrug Resistance, Multiple, BacterialBacterial InfectionsAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedArgentinaProspective StudiesAgedUruguayLogistic ModelsRisk FactorsAdultRisk AssessmentROC Curve

Stichwörter der Autor:innen

antibacterial agentsantibiotic resistanceantimicrobial stewardshipcirrhosisclinical decision makingempirical antibiotic treatment

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Liver Unit and Research Department, Hospital Italiano Buenos Aires, Buenos Aires, Argentina.
  • Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy.
  • Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Unit of Semeiotics, Liver and Alcohol-related diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Institute of Liver and Biliary Sciences, New Delhi, India.

ORCID-Profile: Sebastián Marciano, Salvatore Piano, Virendra Singh, Paolo Caraceni, Rakhi Maiwall, Dong Joon Kim, Sung Eun Kim, Elza Soares, Manuela Merli, Florence Wong, Francois Durand

Zitieren

APA

Marciano, S., Piano, S., Singh, V., Caraceni, P., Maiwall, R., Alessandria, C., Fernandez, J., Kim, D. J., Kim, S. E., Soares, E., Marino, M., Vorobioff, J., Merli, M., Elkrief, L., Vargas, V., Krag, A., Singh, S., Elizondo, M., Anders, M. M., …, & International Club of Ascites Global Study Group (2024). Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis. Liver International. https://doi.org/10.1111/liv.16063

Vancouver

Marciano S, Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, et al. Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis. Liver International. 2024. doi:10.1111/liv.16063

BibTeX
@article{Marciano2024,
  author = {Marciano, Sebastián and Piano, Salvatore and Singh, Virendra and Caraceni, Paolo and Maiwall, Rakhi and Alessandria, Carlo and Fernandez, Javier and Kim, Dong Joon and Kim, Sung Eun and Soares, Elza and Marino, Mónica and Vorobioff, Julio and Merli, Manuela and Elkrief, Laure and Vargas, Victor and Krag, Aleksander and Singh, Shivaram and Elizondo, Martín and Anders, Maria M and Dirchwolf, Melisa and Mendizabal, Manuel and Lesmana, Cosmas R A and Toledo, Claudio and Wong, Florence and Durand, Francois and Gadano, Adrián and Giunta, Diego H and Angeli, Paolo and International Club of Ascites Global Study Group, International Club of Ascites Global Study Group},
  title = {Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.16063}
}
Kostenlos starten →